Canadian Cancer Trials Group Bulletins

Group Administrators Office

Four Canadian Cancer Trials Group Members Inducted as Fellows of the CAHS

Four members of the Canadian Cancer Trials Group, including the Group's Interim Director, Dr. Elizabeth Eisenhauer, have been inducted as fellows of the Canadian Academy of Health Sciences.

Dr. Elizabeth Eisenhauer became Interim Director of the Canadian Cancer Trials Group in July, 2013. She is also Head and Professor of the Department of Oncology at Queen's University and Program Medical Director of the Cancer Centre of Southeastern Ontario at Kingston General Hospital. Prior to taking on these roles, Dr. Eisenhauer was Director of the Canadian Cancer Trials Group's Investigational New Drug Program.

Dr. Carolyn Gotay, member of the Canadian Cancer Trials Group Quality of Life Committee, is Professor and Canadian Cancer Society Chair in Cancer Primary Prevention at the University of British Columbia. She also holds an appointment at the British Columbia Cancer Agency. Her long career in cancer prevention and control research includes leadership experience in academia and in the community.

Dr. Rita Kandel, member of the Canadian Cancer Trials Group Sarcoma Executive Site Committee, is Chief of Pathology and Laboratory Medicine at Mount Sinai Hospital, in Toronto, Ontario, and is also a clinician-scientist and Associate Member of the Lunenfeld-Tanenbaum Research Institute. Dr. Kandel is working towards identifying biomarkers associated with bone and soft tissue tumours. She collaborates closely with Mount Sinai Hospital's clinical Sarcoma Unit, the largest of its kind in Canada, ensuring that the scientific questions being pursued are closely aligned with patient care needs.

Dr. Michael Pollak, member of the Canadian Cancer Trials Group Novel Targets in Breast Cancer Working Group, is a clinical oncologist at the Jewish General Hospital in Montreal, Quebec, and directs a multidisciplinary research program related to cancer endocrinology at the Lady Davis Institute for Medical Research. He is an internationally recognized scientist in this field.

CAHS Fellows are those who have a history of outstanding performance in the academic health sciences in Canada. The new fellows were inducted into the CAHS on September 19 during a dinner ceremony at its Annual General Meeting in Ottawa.

The Canadian Academy of Health Sciences (CAHS) provides timely, informed and unbiased assessments of urgent issues affecting the health of Canadians. These assessments, which are based on evidence reviews and leading expert opinion, provide conclusions and recommendations in the name of CAHS.

Congratulations to all!!!!